
Akinlolu O Ojo MD PhD
Executive Dean, University of Kansas School of Medicine
Join to View Full Profile
3901 Rainbow BoulevardMurphy 3015Kansas City, KS 66160
Phone+1 913-588-7201
Dr. Ojo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Akinlolu Ojo is a nephrologist based in Kansas City, KS, with a specialization in hypertension and kidney transplantation. He completed his medical education at the University of Lagos College of Medicine and furthered his training with a residency in Internal Medicine at the University of Kentucky College of Medicine, followed by a fellowship in Nephrology at the University of Michigan. He has contributed to several peer-reviewed publications on kidney disease and related topics and participated in various clinical trials focused on kidney transplantation and diabetes management post-transplant. His accolades include election to the National Academy of Medicine in 2022 and multiple CMS Meaningful Use Stage 1 Certifications in 2016.
Education & Training
University of MichiganFellowship, Nephrology, 1992 - 1995
University of Kentucky College of MedicineResidency, Internal Medicine, 1988 - 1991
University of Lagos College of MedicineClass of 1985
Certifications & Licensure
KS State Medical License 2019 - 2026
AZ State Medical License 2016 - 2020
MI State Medical License 1992 - 2017
WA State Medical License 1990 - 1992
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Elected member, National Academy of Medicine National Academy of Medicine, 2022
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016
- CMS Meaningful Use Stage 1 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2016
Clinical Trials
Publications & Presentations
PubMed
- Prediction and monitoring of accrual and rate of underrepresented biomedical research group using bayesian methods.Kaustubh S Nimkar, Byron J Gajewski, Dinesh Pal Mudaranthakam, Jeffery A Thompson, Miranda E Handke
BMC Medical Research Methodology. 2026-03-19 - Beverage patterns, blood pressure, and proteinuria among West Africans with chronic kidney disease: a cross-sectional analysis of the diet, CKD, and apolipoprotein L1 ...Rayan Djelmami-Hani, Tolulope Adebile, Runqi Zhao, Edward Kwakyi, Oluwatoyin Amira
Frontiers in Nutrition. 2026-01-01 - 8 citationsAPOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Akinlolu O Ojo, Dwomoa Adu, Kate Bramham, Barry I Freedman, Rasheed A Gbadegesin
Kidney International. 2025-11-01
Press Mentions
KU School of Medicine Embraces Teaching Trauma-Informed Approaches to Patient CareDecember 2nd, 2025
GEHA Funds $1.5 Million Scholarship to Address Lack of Diversity in MedicineSeptember 19th, 2022
Can a Kidney Failure Risk Equation Better Predict ESKD, Regardless of Race?January 11th, 2022
Grant Support
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2026
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2026
- A Clinical Trial To Prevent New Onset Diabetes After TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Renal And Cardiovascular Events In Patients With Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Chronic Renal Insufficiency Cohort (CRIC) StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









